Status:
COMPLETED
Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment
Lead Sponsor:
Posit Science Corporation
Conditions:
Breast Cancer
Cognitive Symptoms
Eligibility:
All Genders
21+ years
Phase:
PHASE1
Brief Summary
The investigators hypothesize that continuous active interaction with environments that are demanding to sensory, cognitive, and motor systems, together with imbedded rewards for successful performanc...
Detailed Description
Breast cancer is the most common malignancy in women in the United States, with an estimated 211,240 new cases of invasive breast cancer diagnosed among women, and 1,700 diagnosed in men, in 2005. Whi...
Eligibility Criteria
Inclusion
- Age 21 or older at the time of consent.
- Diagnosis of invasive breast cancer or recurrence warranting treatment with chemotherapeutic agents in the past 5 years.
- Cognitive decline, as reported by the patient, friends, or family.
- Fluent English speaker.
- Willing and able to commit to the 6-month time requirement of the entire study period.
- Willing to provide informed consent
- Willing to participate in training of the program.
- Agrees to weekly contact
Exclusion
- Severe hearing impairments that would:
- limit the ability to receive instructions and support; and
- hinder performance on the computer training program.
- Self-report of untreated Axis I or II disorders (with the exception of depression, anxiety disorders, and panic disorders).
- Self-report of current diagnosis or history of major neurological illness including, but not limited to:
- Alzheimer's disease
- Parkinson's disease
- Multiple sclerosis
- Amyotrophic lateral sclerosis
- History of a stroke, transient ischemic attack (TIA) or traumatic brain injury within the past year; or lifetime history of stroke, TIA, or traumatic brain injury that has left residual expressive or receptive language problems.
- Self-report of fibromyalgia or symptoms of tremor severe enough to prevent the use of a computer mouse or other pointing device.
- Unwillingness to complete the required assessments.
- Patient is not capable of giving informed consent or unable to comprehend and/or follow instructions.
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2008
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00387062
Start Date
October 1 2006
End Date
June 1 2008
Last Update
June 24 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Posit Science Corporation
San Francisco, California, United States, 94104